The Future of Chronic Kidney Disease Treatment: Combination Therapy (Polypill) or Biomarker-Guided Personalized Intervention?

Chronic kidney disease (CKD) is a global health burden that affects close to one billion individuals. As many healthcare systems struggle to accommodate existing patients, CKD incidence and related costs are projected to continue rising. Based on a systematic search, this narrative review offers an...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Sajjad Biglari, Harald Mischak, Joachim Beige, Agnieszka Latosinska, Justyna Siwy, Mirosław Banasik
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	MDPI AG 2025-06-01
Cyfres:	Biomolecules
Pynciau:	chronic kidney disease therapeutic interventions combination therapy personalized medicine biomarker-guided therapy treatment response prediction
Mynediad Ar-lein:	https://www.mdpi.com/2218-273X/15/6/809
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!